It is interesting to note that whereas E2F1 is up-regulated in breast tumors, its expression is low in prostate tumors [38], which typically have genomes with fewer copy number changes than most ductal invasive breast cancers [39]. The gene discussed is E2F1; the disease is breast neoplasm.